PortfoliosLab logo

Aileron Therapeutics, Inc. (ALRN)

Equity · Currency in USD · Last updated Feb 3, 2023

Company Info

ISINUS00887A1051
CUSIP00887A105
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$2.90
Year Range$1.87 - $13.80
EMA (50)$2.93
EMA (200)$5.04
Average Volume$31.29K
Market Capitalization$13.17M

ALRNShare Price Chart


Loading data...

ALRNPerformance

The chart shows the growth of $10,000 invested in Aileron Therapeutics, Inc. in Sep 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $134 for a total return of roughly -98.66%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%OctoberNovemberDecember2023February
-15.19%
5.37%
ALRN (Aileron Therapeutics, Inc.)
Benchmark (^GSPC)

ALRNCompare to other instruments

Search for stocks, ETFs, and funds to compare with ALRN

Aileron Therapeutics, Inc.

ALRNReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M22.36%8.86%
YTD22.36%8.86%
6M2.18%0.59%
1Y-68.49%-8.07%
5Y-56.26%8.65%
10Y-53.77%10.28%

ALRNMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202317.30%
2022-2.63%11.67%-3.24%-30.75%-14.44%

ALRNSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aileron Therapeutics, Inc. Sharpe ratio is -0.62. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20OctoberNovemberDecember2023February
-0.62
-0.33
ALRN (Aileron Therapeutics, Inc.)
Benchmark (^GSPC)

ALRNDividend History


Aileron Therapeutics, Inc. doesn't pay dividends

ALRNDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%OctoberNovemberDecember2023February
-99.03%
-12.86%
ALRN (Aileron Therapeutics, Inc.)
Benchmark (^GSPC)

ALRNWorst Drawdowns

The table below shows the maximum drawdowns of the Aileron Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aileron Therapeutics, Inc. is 99.37%, recorded on Dec 29, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.37%Oct 5, 20171318Dec 29, 2022
-18.78%Sep 8, 20176Sep 15, 201711Oct 2, 201717
-17.25%Jul 10, 201735Aug 25, 20178Sep 7, 201743
-2.3%Jul 5, 20171Jul 5, 20171Jul 6, 20172
-0.07%Oct 3, 20171Oct 3, 20171Oct 4, 20172

ALRNVolatility Chart

Current Aileron Therapeutics, Inc. volatility is 49.93%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%OctoberNovemberDecember2023February
49.93%
14.65%
ALRN (Aileron Therapeutics, Inc.)
Benchmark (^GSPC)